Related Experiment Video
Updated: Jul 6, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Pathogenesis of COPD. Part II. Oxidative-antioxidative imbalance
1Division of Respiratory Medicine, Department of Medicine, University of Hong Kong, Hong Kong SAR, China. judithmak@hkucc.hku.hk
Summary
Oxidative-antioxidative imbalance in chronic obstructive pulmonary disease (COPD) shows conflicting results. Studies reveal varied antioxidant levels in COPD patients, possibly due to population differences and methods.
Area of Science:
- Pulmonary Medicine
- Biochemistry
- Oxidative Stress Research
Background:
- Chronic obstructive pulmonary disease (COPD) is a significant global health issue, particularly affecting older adults.
- Oxidative-antioxidative imbalance is implicated in COPD pathogenesis and exacerbations.
- Existing research presents conflicting findings regarding oxidative stress markers and antioxidant status in COPD patients.
Purpose of the Study:
- To review and summarize existing literature on the oxidative-antioxidative balance in stable COPD and acute exacerbations.
- To highlight discrepancies in findings related to oxidative stress and antioxidant levels in COPD.
- To explore potential reasons for conflicting results in current research.
Main Methods:
- Systematic review of previous studies on oxidative stress and antioxidant markers in COPD.
- Analysis of data from exhaled air, breath condensates, induced sputum, and plasma.
- Comparison of erythrocyte superoxide dismutase (SOD) and catalase activity in COPD patients versus control groups.
Main Results:
- Studies report increased oxidant production in COPD patients.
- Findings on plasma antioxidant capacity in COPD are contradictory.
- Erythrocyte SOD activity showed varied results, with some studies indicating higher levels in COPD patients and smokers, while others found no difference.
- Elevated erythrocyte catalase activity was observed in Chinese COPD patients compared to matched healthy smokers.
Conclusions:
- Discrepancies in oxidative-antioxidative imbalance research in COPD may stem from inter-individual variations in antioxidant capacity.
- Differences in study populations and methodologies contribute to conflicting findings.
- Further research is needed to clarify the role of oxidative stress and antioxidant status in COPD across diverse populations.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.